ArticleRadiology case reports2026
Bilateral adrenal infarction during brentuximab vedotin plus cyclophosphamide, doxorubicin, and prednisolone therapy for ALK-negative anaplastic large cell lymphoma: A case report.
Article in Radiology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Most bilateral adrenal incidentalomas are neoplastic lesions, and adrenal infarction is a rare cause. In this report, a case of bilateral adrenal infarction in a patient with ALK-negative anaplastic large cell lymphoma is presented, which, to our knowledge, has not been previously reported. A 63-year-old man on day 6 of brentuximab vedotin plus cyclophosphamide, doxorubicin, and prednisolone therapy for ALK-negative anaplastic large cell lymphoma presented with vomiting and pain in the left side of the abdomen and epigastric region. Acute pancreatitis was suspected, and contrast-enhanced computed tomography was performed, revealing bilateral adrenal partial non-enhancement of both adrenal glands. On T2-weighted non-contrast magnetic resonance imaging, moderate hyperintensity was observed in both adrenal glands, along with hyperintensity in the periadrenal region. Based on these findings, a diagnosis of bilateral adrenal infarction was made. No adrenal insufficiency was detected. The patient's symptoms improved after anticoagulant therapy was initiated. Approximately 13 months later, contrast-enhanced computed tomography showed a reduction in the size of both adrenal glands and good contrast enhancement, indicating resolution of the infarction. This case highlights that ALK-negative anaplastic large cell lymphoma and its treatments can cause thrombosis, potentially leading to adrenal infarction. Adrenal infarction should be considered in patients undergoing treatment for hematologic malignancies who present with abdominal symptoms and unexplained adrenal enlargement or enhancement defects on contrast-enhanced computed tomography.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.